SYNTHETIC DEMONSTRATION — no real student or patient. Not a medical device.

pediatric-behavioral

Can Teens Have Clinical Depression? What the Science Says

Yes, teens can have clinical depression — it's common, often shows up as irritability or withdrawal rather than sadness, and responds well to evidence-based treatment.

Talk to a clinician

Dr. Elena Ruiz, MD — Child & Adolescent Psychiatrist

Adolescent depression assessment with the PHQ-A and suicide-risk screening, CBT plus fluoxetine when indicated with close monitoring, and coordination with the teen's school. Gale can match you with a licensed clinician for a visit.

Find care →

Teen depression is real and common

Clinical depression isn't only an adult illness. The World Health Organization reports that depression, anxiety, and behavioral disorders are among the leading causes of illness and disability in adolescents, and that roughly one in seven 10- to 19-year-olds experiences a mental disorder 1. Adolescence is a period of major brain, hormonal, and social change, which can make this age genuinely vulnerable. Depression in a teenager is a real medical condition — not 'just hormones,' a phase to wait out, or a discipline problem.

It often looks different in teens

One reason teen depression gets missed is that it doesn't always look like sadness. In adolescents it commonly shows up as irritability or anger, withdrawal from friends and family, a drop in grades, loss of interest in activities they used to love, changes in sleep and appetite, or vague physical complaints like headaches and stomachaches. NIMH's guidance for families highlights exactly these kinds of warning signs and emphasizes knowing when to seek help 3. A teen who has become unusually irritable, isolated, or checked out may be describing depression in the only language they have.

Screening that catches it

Because teen depression is common and treatable, major bodies recommend looking for it proactively. The US Preventive Services Task Force recommends screening for major depressive disorder in adolescents aged 12 to 18 (a 'B' recommendation), where systems are in place to support diagnosis and follow-up 2. Primary-care guidelines (GLAD-PC) similarly recommend annual systematic depression screening starting around age 12 4. These screens often use a validated tool — the PHQ-9 Modified for Adolescents (PHQ-A) — designed and validated specifically for this age group to gauge symptom severity 5. Screening is a starting conversation, not a diagnosis on its own.

When a clinician helps

A clinician brings several things a parent can't provide alone. They can administer validated tools like the PHQ-A to confirm whether what you're seeing is depression and how severe it is 5, and screen for safety, since adolescent depression and suicide risk are assessed together 2. They can help rule out medical contributors. And they can offer evidence-based treatment: the landmark NIMH-funded TADS trial found that combining the antidepressant fluoxetine with cognitive behavioral therapy (CBT) gave the most favorable benefit-to-risk balance for adolescent depression 6, and follow-up showed combination treatment sped recovery while underscoring the need to monitor for suicidal events when antidepressants are used 7. A clinician also coordinates with the teen's school so symptoms aren't mistaken for misbehavior.

What treatment looks like

Treatment for adolescent depression typically starts with psychotherapy such as CBT, with medication added based on severity and response; fluoxetine is the antidepressant with the strongest evidence and the usual first choice in youth 8. Cochrane reviews of newer-generation antidepressants in young people show real but modest benefits over placebo and stress the importance of close monitoring of suicide-related outcomes during treatment 8. The encouraging bottom line for families: adolescent depression is treatable, most teens improve, and early, well-monitored care gives the best odds. Treatment is a collaboration between the teen, the family, and the clinical team.

Common questions

Isn't moodiness just a normal part of being a teenager?

Some ups and downs are normal. Depression is different — it's persistent low mood or irritability and loss of interest lasting two weeks or more, with a real impact on school, friendships, sleep, and daily life. When in doubt, a screening conversation with a clinician can help sort it out.

At what age should teens be screened for depression?

The US Preventive Services Task Force recommends screening for major depression in adolescents aged 12 to 18, and primary-care guidelines recommend annual screening starting around age 12, using validated tools like the PHQ-A.

What's the most effective treatment for teen depression?

Evidence from the TADS trial supports combining cognitive behavioral therapy (CBT) with the antidepressant fluoxetine for the most favorable benefit-to-risk balance, with close monitoring. Therapy alone is often the starting point depending on severity.

Talk to a clinician

Dr. Elena Ruiz, MD — Child & Adolescent Psychiatrist

Adolescent depression assessment with the PHQ-A and suicide-risk screening, CBT plus fluoxetine when indicated with close monitoring, and coordination with the teen's school. Gale can match you with a licensed clinician for a visit.

Find care →

Warning signs in a teen — when to act

  • —Persistent irritability, sadness, or withdrawal lasting two weeks or more
  • —Loss of interest in friends, activities, or school
  • —Marked changes in sleep, appetite, or grades
  • —Talk of hopelessness, being a burden, or not wanting to be here
  • —Any mention of suicide, self-harm, or giving away belongings

If a teen is in immediate danger or talking about suicide, call or text 988 (Suicide & Crisis Lifeline), text HOME to 741741, or call 911.

This article is educational and is not a diagnosis or a substitute for personalized care from a licensed clinician.

References

  1. 1.World Health Organization (2024). Mental Health of Adolescents (Fact Sheet). World Health Organization (who.int). link ✓WHO reports depression, anxiety and behavioral disorders are leading causes of adolescent illness and that one in seven 10-19-year-olds experiences a mental disorder.
  2. 2.US Preventive Services Task Force (Mangione CM, Barry MJ, Nicholson WK, et al.) (2022). Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. doi:10.1001/jama.2022.16946 ✓The USPSTF recommends screening for major depressive disorder in adolescents aged 12 to 18 (B recommendation), assessed alongside suicide risk.
  3. 3.National Institute of Mental Health (NIMH) (2024). Child and Adolescent Mental Health. National Institute of Mental Health (nimh.nih.gov). link ✓NIMH outlines warning signs of depression in children and adolescents and guidance on when to seek help.
  4. 4.Zuckerbrot RA, Cheung A, Jensen PS, Stein REK, Laraque D; GLAD-PC Steering Group (2018). Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice Preparation, Identification, Assessment, and Initial Management. Pediatrics. doi:10.1542/peds.2017-4081 ✓GLAD-PC recommends annual systematic depression screening of adolescents ages 12 and up in primary care.
  5. 5.National Institute of Mental Health (NIMH) / Ask Suicide-Screening Questions (ASQ) Toolkit (2024). PHQ-9 Modified for Adolescents (PHQ-A). National Institute of Mental Health (nimh.nih.gov). link ✓The PHQ-9 Modified for Adolescents (PHQ-A) is an NIMH-hosted validated instrument used to screen and gauge severity of adolescent depressive symptoms.
  6. 6.March J, Silva S, Petrycki S, et al. (Treatment for Adolescents With Depression Study Team) (2004). Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents With Depression: Treatment for Adolescents With Depression Study (TADS) Randomized Controlled Trial. JAMA. doi:10.1001/jama.292.7.807 ✓The TADS RCT found combining fluoxetine with CBT offered the most favorable benefit-to-risk balance for adolescent major depression.
  7. 7.March JS, Silva S, Petrycki S, et al. (TADS Team) (2007). The Treatment for Adolescents With Depression Study (TADS): Long-term Effectiveness and Safety Outcomes. Archives of General Psychiatry. doi:10.1001/archpsyc.64.10.1132 ✓TADS follow-up showed combination treatment accelerated recovery while suicidal events were more frequent in fluoxetine-containing arms, underscoring monitoring.
  8. 8.Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, Cox GR, Merry SN, Meader N (2021). New Generation Antidepressants for Depression in Children and Adolescents: A Network Meta-Analysis. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD013674.pub2 ✓Cochrane network meta-analysis identifies fluoxetine as the first-line antidepressant in youth, with generally small benefits and a need to monitor suicide-related outcomes.

8 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.